Susquehanna International Group’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.17M Buy
763,981
+334,876
+78% +$3.14M ﹤0.01% 969
2025
Q1
$3.05M Sell
429,105
-98,515
-19% -$700K ﹤0.01% 1754
2024
Q4
$6.15M Buy
527,620
+110,569
+27% +$1.29M ﹤0.01% 975
2024
Q3
$8.57M Buy
417,051
+196,413
+89% +$4.04M ﹤0.01% 722
2024
Q2
$4.94M Buy
220,638
+121,114
+122% +$2.71M ﹤0.01% 1035
2024
Q1
$2.74M Sell
99,524
-95,975
-49% -$2.64M ﹤0.01% 1493
2023
Q4
$5.96M Buy
195,499
+87,710
+81% +$2.67M ﹤0.01% 1033
2023
Q3
$3.41M Sell
107,789
-89,859
-45% -$2.84M ﹤0.01% 1382
2023
Q2
$8.06M Buy
197,648
+54,046
+38% +$2.2M ﹤0.01% 817
2023
Q1
$5.35M Buy
143,602
+19,347
+16% +$721K ﹤0.01% 1078
2022
Q4
$4.34M Buy
124,255
+9,129
+8% +$319K ﹤0.01% 1052
2022
Q3
$6.44M Buy
115,126
+35,985
+45% +$2.01M ﹤0.01% 691
2022
Q2
$4.1M Buy
79,141
+18,862
+31% +$976K ﹤0.01% 1062
2022
Q1
$4.38M Buy
60,279
+22,854
+61% +$1.66M ﹤0.01% 1264
2021
Q4
$4.43M Sell
37,425
-47,776
-56% -$5.65M ﹤0.01% 1280
2021
Q3
$11.4M Buy
85,201
+66,049
+345% +$8.86M ﹤0.01% 703
2021
Q2
$3.1M Buy
19,152
+4,227
+28% +$684K ﹤0.01% 1657
2021
Q1
$1.2M Sell
14,925
-59,060
-80% -$4.74M ﹤0.01% 2748
2020
Q4
$4.03M Sell
73,985
-71,253
-49% -$3.88M ﹤0.01% 1158
2020
Q3
$2.89M Buy
145,238
+94,461
+186% +$1.88M ﹤0.01% 1166
2020
Q2
$1.07M Sell
50,777
-36,103
-42% -$759K ﹤0.01% 2086
2020
Q1
$1.06M Buy
86,880
+13,757
+19% +$168K ﹤0.01% 1972
2019
Q4
$1.07M Sell
73,123
-2,525
-3% -$37.1K ﹤0.01% 1832
2019
Q3
$1.01M Sell
75,648
-46,362
-38% -$619K ﹤0.01% 2010
2019
Q2
$2M Buy
122,010
+108,901
+831% +$1.78M ﹤0.01% 1263
2019
Q1
$224K Sell
13,109
-9,526
-42% -$163K ﹤0.01% 2467
2018
Q4
$309K Buy
22,635
+10,792
+91% +$147K ﹤0.01% 2556
2018
Q3
$339K Buy
+11,843
New +$339K ﹤0.01% 2311
2018
Q2
Hold
0
4336
2018
Q1
Sell
-24,093
Closed -$463K 4150
2017
Q4
$463K Sell
24,093
-18,585
-44% -$357K ﹤0.01% 2461
2017
Q3
$1.06M Buy
+42,678
New +$1.06M ﹤0.01% 1614
2017
Q2
Hold
0
4078
2017
Q1
Sell
-36,415
Closed -$477K 4030
2016
Q4
$477K Buy
+36,415
New +$477K ﹤0.01% 3017